Kwangdong Healthbio Co's quarterly market cap
declined
from Dec. 2021 (₩26,382 Mil) to Dec. 2022 (₩23,262 Mil) but then
increased
from Dec. 2022 (₩23,262 Mil) to Dec. 2023 (₩28,549 Mil).
Kwangdong Healthbio Co's annual market cap
declined
from Dec. 2021 (₩26,382 Mil) to Dec. 2022 (₩23,262 Mil) but then
increased
from Dec. 2022 (₩23,262 Mil) to Dec. 2023 (₩28,549 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kwangdong Healthbio Co's Enterprise Value for Today is ₩53,215 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kwangdong Healthbio Co's Market Cap
For the Household & Personal Products subindustry, Kwangdong Healthbio Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kwangdong Healthbio Co's Market Cap Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kwangdong Healthbio Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Kwangdong Healthbio Co's Market Cap falls into.
Kwangdong Healthbio Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kwangdong Healthbio Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kwangdong Healthbio Co (XKRX:086220) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kwangdong Healthbio Co Market Cap Related Terms
Thank you for viewing the detailed overview of Kwangdong Healthbio Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kwangdong Healthbio Co (XKRX:086220) Business Description
BL Healthcare Corp is a Bio-venture company, which develops, manufactures, and sells health functional food and pharmaceutical products. The Company's products include weight-loss pills, vitamins, and other nutrition supplements. It also produces personal care items such as cosmetics, hair care products, and skincare products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:086220 has been successfully added to your 